Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 69301-69350 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05868902
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
N/A
Recruiting
300 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT05857761
GAIN Symptoms: Post-traumatic Headache
NA
Active, not recruiting
62 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2027
3 conditions
3 sponsors
1 location
NCT06238609
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
NA
Active, not recruiting
25 participants
Started: Aug 28, 2023 · Completed: Aug 28, 2025
3 conditions
2 sponsors
1 location
NCT05985356
Neuromodulation for Comorbid Hoarding Disorder and Depression
NA
Active, not recruiting
12 participants
Started: Aug 28, 2023 · Completed: Apr 30, 2025
3 conditions
1 sponsor
1 location
NCT06181838
Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction
NA
Active, not recruiting
40 participants
Started: Aug 28, 2023 · Completed: Jan 3, 2024
2 conditions
1 sponsor
1 location
NCT06044831
Expanded Population Health Model Evaluation
N/A
Recruiting
300 participants
Started: Aug 28, 2023 · Completed: Oct 31, 2026
2 conditions
2 sponsors
1 location
NCT05955924
Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
PHASE3
Recruiting
396 participants
Started: Aug 28, 2023 · Completed: Aug 31, 2027
4 conditions
4 sponsors
7 locations
NCT06126224
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
PHASE3
Active, not recruiting
400 participants
Started: Aug 28, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
119 locations
NCT05995054
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia
PHASE2
Recruiting
110 participants
Started: Aug 28, 2023 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT05941052
Assessing Diagnostics At Point-of-care for Tuberculosis
NA
Recruiting
1,350 participants
Started: Aug 28, 2023 · Completed: Sep 30, 2028
1 condition
8 sponsors
3 locations
NCT05975268
A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
PHASE3
Active, not recruiting
747 participants
Started: Aug 28, 2023 · Completed: Oct 29, 2025
1 condition
1 sponsor
63 locations
NCT06207760
Effect of Minocycline on Inflammation in Depressed Patients
PHASE2
Recruiting
60 participants
Started: Aug 28, 2023 · Completed: Apr 30, 2024
1 condition
2 sponsors
1 location
NCT07021677
"Use of a New Medicine Daratumumab to Treat Left-over Cancer in a Blood Cancer Called T Acute Lymphoblastic Leukemia"
PHASE2
Recruiting
18 participants
Started: Aug 28, 2023 · Completed: Aug 28, 2026
1 condition
1 sponsor
1 location
NCT06390059
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2
Active, not recruiting
84 participants
Started: Aug 28, 2023 · Completed: Nov 27, 2025
1 condition
1 sponsor
15 locations
NCT05942313
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
N/A
Recruiting
100 participants
Started: Aug 28, 2023 · Completed: Dec 1, 2025
2 conditions
3 sponsors
1 location
NCT06183645
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
N/A
Recruiting
40 participants
Started: Aug 28, 2023 · Completed: Jan 31, 2028
1 condition
3 sponsors
1 location
NCT06021964
Prospective Cohort Observational Study of Placenta Accreta Spectrum Disorders
N/A
Enrolling by invitation
1,000 participants
Started: Aug 28, 2023 · Completed: Dec 7, 2025
1 condition
8 sponsors
1 location
NCT06006195
Investigating the Correlations Between Dysphagia Symptoms and Swallowing Muscle Groups by HRPM-I
N/A
Not yet recruiting
50 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2030
1 condition
1 sponsor
0 locations
NCT05956015
Albumin Catabolic Rate Measured by a Stable Isotope
NA
Not yet recruiting
24 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05959746
Clinical Development of a Tool for Optimized Self- and Hetero-diagnosis of Stroke Using Artificial Intelligence: Stage1- Collection of Video-clinical Data in a Pragmatic Situation.
NA
Recruiting
300 participants
Started: Aug 28, 2023 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT06006026
The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery
NA
Recruiting
9 participants
Started: Aug 28, 2023 · Completed: May 20, 2024
1 condition
1 sponsor
1 location
NCT06144736
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
PHASE2
Recruiting
60 participants
Started: Aug 28, 2023 · Completed: Aug 31, 2029
1 condition
1 sponsor
1 location
NCT05719428
Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies
PHASE2
Recruiting
37 participants
Started: Aug 28, 2023 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT05990452
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
261 participants
Started: Aug 28, 2023 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT05866757
Discontinuation Study
NA
Recruiting
70 participants
Started: Aug 28, 2023 · Completed: Sep 30, 2028
3 conditions
2 sponsors
1 location
NCT05797233
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
PHASE1
Active, not recruiting
58 participants
Started: Aug 28, 2023 · Completed: Dec 30, 2029
3 conditions
1 sponsor
1 location
NCT05660395
A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)
PHASE1
Recruiting
56 participants
Started: Aug 28, 2023 · Completed: Apr 5, 2027
2 conditions
1 sponsor
14 locations
NCT06228976
Mindfulness-based, Mobile Health (mHealth) Smoking Cessation Intervention in Vietnam
NA
Recruiting
1,200 participants
Started: Aug 27, 2023 · Completed: Dec 31, 2024
4 conditions
4 sponsors
1 location
NCT06115980
Safety and Preliminary Performance of Xtrac O.S. System for Lead Extraction.
NA
Recruiting
10 participants
Started: Aug 27, 2023 · Completed: Jul 20, 2025
1 condition
3 sponsors
1 location
NCT06105840
Combination of Curcuminoid With Acupressure for Inflammation and Pain in the Elderly With Osteoarthritis Genu
PHASE1/PHASE2
Enrolling by invitation
70 participants
Started: Aug 27, 2023 · Completed: Oct 31, 2023
1 condition
1 sponsor
1 location
NCT06149988
Comparative PK Study Of THC/CBD Formulations
PHASE1
Recruiting
14 participants
Started: Aug 27, 2023 · Completed: Feb 1, 2024
1 condition
1 sponsor
1 location
NCT05990881
Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
PHASE3
Recruiting
50 participants
Started: Aug 27, 2023 · Completed: Jul 31, 2026
3 conditions
1 sponsor
1 location
NCT05975554
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
NA
Active, not recruiting
30 participants
Started: Aug 26, 2023 · Completed: Sep 1, 2025
3 conditions
1 sponsor
1 location
NCT05660265
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
PHASE1
Recruiting
40 participants
Started: Aug 26, 2023 · Completed: Feb 27, 2026
2 conditions
1 sponsor
8 locations
NCT05125822
Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity
NA
Recruiting
260 participants
Started: Aug 26, 2023 · Completed: Jan 1, 2028
1 condition
1 sponsor
1 location
NCT06024876
A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia
EARLY_PHASE1
Active, not recruiting
5 participants
Started: Aug 26, 2023 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05997043
Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease
EARLY_PHASE1
Recruiting
60 participants
Started: Aug 26, 2023 · Completed: Jul 1, 2026
3 conditions
1 sponsor
1 location
NCT06039267
Brain Health & the Microbiome
N/A
Active, not recruiting
90 participants
Started: Aug 25, 2023 · Completed: Aug 24, 2025
3 conditions
1 sponsor
1 location
NCT05749887
The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.
NA
Recruiting
188 participants
Started: Aug 25, 2023 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT05801835
A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
NA
Recruiting
36 participants
Started: Aug 25, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05954910
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
N/A
Active, not recruiting
1,000 participants
Started: Aug 25, 2023 · Completed: May 31, 2027
1 condition
1 sponsor
29 locations
NCT05856799
Danish Randomized Trial on Leadless vs Transvenous Pacing
NA
Recruiting
80 participants
Started: Aug 25, 2023 · Completed: Jun 30, 2026
1 condition
3 sponsors
2 locations
NCT05899465
Perioperative Treatment With Tranexamic Acid in Melanoma
PHASE3
Recruiting
1,204 participants
Started: Aug 25, 2023 · Completed: Sep 1, 2028
1 condition
3 sponsors
5 locations
NCT06570980
Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.
N/A
Recruiting
200 participants
Started: Aug 25, 2023 · Completed: Aug 30, 2024
1 condition
1 sponsor
1 location
NCT05593055
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
PHASE4
Recruiting
75 participants
Started: Aug 25, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05978986
Efficiency of Determining the Clinical Class of Chronic Venous Disorders by Artificial Intelligence
NA
Recruiting
1,530 participants
Started: Aug 25, 2023 · Completed: Dec 15, 2025
2 conditions
1 sponsor
3 locations
NCT06013410
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NA
Recruiting
30 participants
Started: Aug 25, 2023 · Completed: May 15, 2026
1 condition
2 sponsors
1 location
NCT05956626
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
PHASE2/PHASE3
Recruiting
51 participants
Started: Aug 25, 2023 · Completed: Sep 28, 2026
1 condition
1 sponsor
14 locations
NCT06089525
Treatment of Complex Pilon Fractures
N/A
Recruiting
30 participants
Started: Aug 25, 2023 · Completed: Dec 25, 2023
1 condition
2 sponsors
1 location
NCT06026605
A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors
EARLY_PHASE1
Recruiting
44 participants
Started: Aug 25, 2023 · Completed: Aug 30, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
1384
1385
1386
1387
1388
1389
1390
More pages
2369
Next